Comments
Loading...

CG Oncology Earnings Estimates

CGONNASDAQ
Logo brought to you by Benzinga Data

CG Oncology Earnings Estimates, EPS & Revenue | NASDAQ:CGON | Benzinga

CG Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
May 13
EPS
$-0.450
Quarterly Revenue
$52.00K
Annual Revenue
(as of Mar 31)
$662.00K

Analyze the earnings history of CG Oncology using advanced sorting and filters.

Get Alert
CGONCG Oncology-$0.28$0.0008/07/2025Get Alert
CGONCG Oncology-$0.36-$0.28-$0.45-60.71%$529.00K$144.61K$52.00K-64.04%05/13/2025Get Alert
CGONCG Oncology-$0.39-$0.46-17.95%$51.53K$456.00K784.92%03/28/2025Get Alert
CGONCG Oncology-$4.00-$0.36-$0.3016.67%$100.00K$0.00-100.00%11/12/2024Get Alert
CGONCG Oncology-$3.93-$0.37-$0.2824.32%$0.00$0.0008/08/2024Get Alert
CGONCG Oncology-$3.22-$0.31-$0.36-16.13%$0.00$0.0005/09/2024Get Alert

CG Oncology (CGON) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q12025-05-13$-0.45$-0.28-60.7 %
Q42025-03-28$-0.46$-0.39-17.9 %
Q32024-11-12$-0.30$-0.3616.7 %
Q22024-08-08$-0.28$-0.3724.3 %

CG Oncology (CGON) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q12025-05-13$52.00K$144.61K-64.0 %
Q42025-03-28$456.00K$51.53K784.9 %
Q32024-11-12$0$100.00K-100.0 %

FAQ

Q

When is CG Oncology (NASDAQ:CGON) reporting earnings?

A

CG Oncology (CGON) is scheduled to report earnings on August 7, 2025. The last reported earnings were for reported on May 13, 2025 for Q1.

Q

What were the latest earnings per share (EPS) for CG Oncology (NASDAQ:CGON)?

A

The Actual EPS was $-0.45, which missed the estimate of $-0.28.

Q

What were CG Oncology’s (NASDAQ:CGON) revenues?

A

The Actual Revenue was $52K, which missed the estimate of $144.6K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch